RAPT Therapeutics, Inc. — Director's Dealing 2021

Nov 11, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: RAPT Therapeutics, Inc. (RAPT)
CIK: 0001673772
Period of Report: 2021-11-09

Reporting Person: Lyons-Williams Lori (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$30.76	2025-06-07	Common Stock (1800)		Direct

Footnotes

F1: 1/6th of the shares subject to the option shall vest on each monthly anniversary of the vesting start date of June 7, 2021.